Your Article Summary
See Latest ArticlesCritical Role for IL-6 in Hypertrophy and Fibrosis in Chronic Cardiac Allograft Rejection
American Journal of Transplantation, 06/18/09
Diaz JA et al. - The observations reveal a new paradigm in which IL-6 drives development of pathologic hypertrophy and fibrosis in chronic cardiac allograft rejection and suggest that IL-6 could be a therapeutic target to prevent this disease.
Related Articles
Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants
European Journal of Immunology, 10/26/09
Relevance Score: 69%
Evaluation of serum tumor necrosis factor [alpha] and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
Saudi Journal of Kidney Diseases and Transplantation, 11/06/09
Relevance Score: 68%
Morbimortality in Heart and Lung Transplantation in Cuba: A 20-Year Follow-up
Transplantation Proceedings, 11/13/09
Relevance Score: 66%
Systemic sclerosis as a model of chronic rejection in facial composite tissue transplantation
Journal of Plastic, Reconstructive & Aesthetic Surgery, 10/06/09
Relevance Score: 66%
Treatment Strategies to Minimize or Prevent Chronic Allograft Dysfunction in Pediatric Renal Transplant Recipients
Pediatric Drugs, 11/05/09
Relevance Score: 65%
Today in Transplant/Augmentation...keeping you current
Receive free subspecialty "5-minute updates" via email
Heart Transplantation in a Low-Organ-Donation Environment: A Single Center Experience
Transplantation Proceedings, 12/17/09
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis
Transfusion, 12/17/09
Smoking Among Women Following Heart Transplantation: Should We Be Concerned
Progress in Cardiovascular Nursing, 12/16/09